B. Metzler Seel. Sohn & Co. Ag Tandem Diabetes Care Inc Transaction History

B. Metzler Seel. Sohn & Co. Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$35.86 - $46.5 $65,480 - $84,909	1,826 Added 10.5%	19,209 $780,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $22,492 - $35,450	514 Added 3.05%	17,383 $832,000
Q2 2022 Aug 12, 2022	BUY	$53.22 - $123.09 $303,513 - $701,982	5,703 Added 51.07%	16,869 $998,000
Q1 2022 May 10, 2022	BUY	$101.89 - $150.09 $1.14 Million - $1.68 Million	11,166 New	11,166 $1.3 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.